2015 – 2025 GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET FORECAST & OPPORTUNITIES
www.techsciresearch.com MARKET INTELLIGENCE . CONSULTING
Scope of Report Product of Interest (POI): Therapeutic Plasma Exchange
The global therapeutic plasma exchange market is expected to witness significant growth over the next five years on account of increase in prevalence of chronic diseases and increase in application of therapeutic plasma exchange. Based on indication, market can be segregated into neurological disorders, renal disorders, hematology disorders, and metabolic disorders.
Market Segmentation INDICATION
TECHNIQUE
•
Neurological Disorders
•
Centrifugation
•
Renal Disorders
•
Membrane Separation
•
Hematology Disorders
•
Metabolic Disorders
GENDER
Review Period
2015 – 2018 REGION
END USE
Year Range
•
North America
•
Europe
Hospitals
•
Middle East & Africa
•
•
Male
Asia-Pacific
•
Clinics
•
•
Female
Others
•
South America
•
Base Year
2019 Estimated Year
2020 Forecast Period
2021 – 2025
2
Table of Contents S. No.
Contents
1.
Product Overview
2.
Research Methodology
3.
Executive Summary
4.
Voice of Customer
5.
Global Therapeutic Plasma Exchange Market Outlook 5.1.
Market Size & Forecast 5.1.1.
5.2.
5.3. 6.
Page No.
By Value
Market Share & Forecast 5.2.1.
By Technique (Centrifugation v/s Membrane Separation)
5.2.2.
By Indication (Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders)
5.2.3.
By Gender (Male v/s Female)
5.2.4
By End Use (Hospitals, Clinics, Others)
5.2.5.
By Region (Asia-Pacific, Europe, North America, South America, Middle East & Africa)
5.2.6.
By Company (2019)
Product Market Map
Asia-Pacific Therapeutic Plasma Exchange Market Outlook 6.1.
Market Size & Forecast 6.1.1.
By Value
3
Table of Contents S. No.
Contents 6.2.
6.3.
Page No.
Market Share & Forecast 6.2.1.
By Technique
6.2.2.
By Indication
6.2.3.
By End Use
6.2.4.
By Country
Asia-Pacific: Country Analysis 6.3.1.
China Therapeutic Plasma Exchange Market Outlook 6.3.1.1.
Market Size & Forecast 6.3.1.1.1.
6.3.1.2.
6.3.2.
Market Share & Forecast 6.3.1.2.1.
By Technique
6.3.1.2.2.
By Indication
6.3.1.2.3.
By End Use
India Therapeutic Plasma Exchange Market Outlook 6.3.2.1.
Market Size & Forecast 6.3.2.1.1.
6.3.2.2.
6.3.3.
By Value
By Value
Market Share & Forecast 6.3.2.2.1.
By Technique
6.3.2.2.2.
By Indication
6.3.2.2.3.
By End Use
Japan Therapeutic Plasma Exchange Market Outlook 6.3.3.1.
Market Size & Forecast
4
Table of Contents S. No.
Contents 6.3.3.1.1. 6.3.3.2.
6.3.4.
Market Share & Forecast 6.3.3.2.1.
By Technique
6.3.3.2.2.
By Indication
6.3.3.2.3.
By End Use
Market Size & Forecast 6.3.4.1.1.
6.3.4.2.
By Value
Market Share & Forecast 6.3.4.2.1.
By Technique
6.3.4.2.2.
By Indication
6.3.4.2.3.
By End Use
Australia Therapeutic Plasma Exchange Market Outlook 6.3.5.1.
Market Size & Forecast 6.3.5.1.1.
6.3.5.2.
7.
By Value
South Korea Therapeutic Plasma Exchange Market Outlook 6.3.4.1.
6.3.5.
Page No.
By Value
Market Share & Forecast 6.3.5.2.1.
By Technique
6.3.5.2.2.
By Indication
6.3.5.2.3.
By End Use
Europe Therapeutic Plasma Exchange Market Outlook 7.1.
Market Size & Forecast 7.1.1.
7.2.
By Value
Market Share & Forecast
5
Table of Contents S. No.
Contents
7.3.
7.2.1.
By Technique
7.2.2.
By Indication
7.2.3.
By End Use
7.2.4.
By Country
Page No.
Europe: Country Analysis 7.3.1.
France Therapeutic Plasma Exchange Market Outlook 7.3.1.1.
Market Size & Forecast 7.3.1.1.1.
7.3.1.2.
7.3.2.
Market Share & Forecast 7.3.1.2.1.
By Technique
7.3.1.2.2.
By Indication
7.3.1.2.3.
By End Use
Germany Therapeutic Plasma Exchange Market Outlook 7.3.2.1.
Market Size & Forecast 7.3.2.1.1.
7.3.2.2.
7.3.3.
By Value
By Value
Market Share & Forecast 7.3.2.2.1.
By Technique
7.3.2.2.2.
By Indication
7.3.2.2.3.
By End Use
United Kingdom Therapeutic Plasma Exchange Market Outlook 7.3.3.1.
Market Size & Forecast 7.3.3.1.1.
7.3.3.2.
By Value
Market Share & Forecast
6
Table of Contents S. No.
Contents
7.3.4.
7.3.3.2.1.
By Technique
7.3.3.2.2.
By Indication
7.3.3.2.3.
By End Use
Italy Therapeutic Plasma Exchange Market Outlook 7.3.4.1.
Market Size & Forecast 7.3.4.1.1.
7.3.4.2.
7.3.5.
By Value
Market Share & Forecast 7.3.4.2.1.
By Technique
7.3.4.2.2.
By Indication
7.3.4.2.3.
By End Use
Spain Therapeutic Plasma Exchange Market Outlook 7.3.5.1.
Market Size & Forecast 7.3.5.1.1.
7.3.5.2.
8.
Page No.
By Value
Market Share & Forecast 7.3.5.2.1.
By Technique
7.3.5.2.2.
By Indication
7.3.5.2.3.
By End Use
North America Therapeutic Plasma Exchange Market Outlook 8.1.
Market Size & Forecast 8.1.1.
8.2.
By Value
Market Share & Forecast 8.2.1.
By Technique
8.2.2.
By Indication
7
Table of Contents S. No.
Contents
8.3.
8.2.3.
By End Use
8.2.4.
By Country
Page No.
North America: Country Analysis 8.3.1.
United States Therapeutic Plasma Exchange Market Outlook 8.3.1.1.
Market Size & Forecast 8.3.1.1.1.
8.3.1.2.
8.3.2.
Market Share & Forecast 8.3.1.2.1.
By Technique
8.3.1.2.2.
By Indication
8.3.1.2.3.
By End Use
Mexico Therapeutic Plasma Exchange Market Outlook 8.3.2.1.
Market Size & Forecast
8.3.2.1.1. 8.3.2.2.
8.3.3.
By Value
By Value
Market Share & Forecast 8.3.2.2.1.
By Technique
8.3.2.2.2.
By Indication
8.3.2.2.3.
By End Use
Canada Therapeutic Plasma Exchange Market Outlook 8.3.3.1.
Market Size & Forecast 8.3.3.1.1.
8.3.3.2.
By Value
Market Share & Forecast 8.3.3.2.1.
By Technique
8.3.3.2.2.
By Indication
8
Table of Contents S. No.
Contents 8.3.3.2.3.
9.
Page No.
By End Use
South America Therapeutic Plasma Exchange Market Outlook 9.1.
Market Size & Forecast 9.1.1.
9.2.
9.3.
By Value
Market Share & Forecast 9.2.1.
By Technique
9.2.2.
By Indication
9.2.3.
By End Use
9.2.4.
By Country
South America: Country Analysis 9.3.1.
Brazil Therapeutic Plasma Exchange Market Outlook 9.3.1.1.
Market Size & Forecast
9.3.1.1.1. 9.3.1.2.
9.3.2.
By Value
Market Share & Forecast 9.3.1.2.1.
By Technique
9.3.1.2.2.
By Indication
9.3.1.2.3.
By End Use
Argentina Therapeutic Plasma Exchange Market Outlook 9.3.2.1.
Market Size & Forecast 9.3.2.1.1
9.3.2.2.
By Value
Market Share & Forecast 9.3.2.2.1.
By Technique
9.3.2.2.2.
By Indication
9
Table of Contents S. No.
Contents 9.3.2.2.3. 9.3.3.
By End Use
Colombia Therapeutic Plasma Exchange Market Outlook 9.3.3.1.
Market Size & Forecast 9.3.3.1.1.
9.3.3.2.
10.
Page No.
By Value
Market Share & Forecast 9.3.3.2.1.
By Technique
9.3.3.2.2.
By Indication
9.3.3.2.3.
By End Use
Middle East & Africa Therapeutic Plasma Exchange Market Outlook 10.1.
Market Size & Forecast 10.1.1.
10.2.
10.3.
By Value
Market Share & Forecast
10.2.1.
By Technique
10.2.2.
By Indication
10.2.3.
By End Use
10.2.4.
By Country
Middle East & Africa: Country Analysis 10.3.1.
South Africa Therapeutic Plasma Exchange Market Outlook 10.3.1.1.
Market Size & Forecast 10.3.1.1.1.
10.3.1.2.
By Value
Market Share & Forecast 10.3.1.2.1.
By Technique
10.3.1.2.2.
By Indication
10
Table of Contents S. No.
Contents 10.3.1.2.3. 10.3.2.
Market Size & Forecast 10.3.2.1.1.
10.3.2.2.
By Value
Market Share & Forecast 10.3.2.2.1.
By Technique
10.3.2.2.2.
By Indication
10.3.2.2.3.
By End Use
UAE Therapeutic Plasma Exchange Market Outlook 10.3.3.1.
Market Size & Forecast 10.3.3.1.1.
10.3.3.2.
11.
By End Use
Saudi Arabia Therapeutic Plasma Exchange Market Outlook 10.3.2.1.
10.3.3.
Page No.
By Value
Market Share & Forecast
10.3.3.2.1.
By Technique
10.3.3.2.2.
By Indication
10.3.3.2.3.
By End Use
Market Dynamics 11.1.
Drivers
11.2.
Challenges
12.
Market Trends and Developments
13.
Competitive Landscape 13.2.
Company Profiles (Leading 10 Global Player)
14.
Strategic Recommendations
15.
About Us and Disclaimer
11
RESEARCH METHODOLOGY
Research Methodology
Market Profiling
In-depth secondary research was conducted to determine top players in the global therapeutic plasma exchange market, overall market size and segmental market size.
Formulating Questionnaire
In order to conduct industry experts’ interviews, TechSci formulated a detailed discussion guide.
Developing List of Respondents
Data Collection
Data Validation
Data obtained as a result of primary and secondary research was validated through rigorous triangulation.
TechSci conducted interviews with industry experts and industry players for data collection and verification.
List of industry players and industry specialists was developed.
Primary Research
Data Collection
Data Filter & Analysis
Research & Intelligence
Actionable Insights
Business Solution
LinkedIn TechSci Internal Database
✓ Recent Developments ✓ Market Changing Aspects/Dynamics ✓ Government Policies ✓ Conclusion
✓ Identifying Key Opinion Leaders ✓ Questionnaire Design ✓ In-depth Interviews
Primary Research ✓ ✓
Desk Research
Secondary Research ✓ ✓ ✓ ✓ ✓ ✓ ✓
Company Websites Company Annual Reports White Paper Study Financial Reports Investor Presentations Regulatory Body Associations, etc.
Data Analysis
The data was scrutinized using MS-Excel, statistical tools and internal proprietary database to obtain qualitative and quantitative insights about the global therapeutic plasma exchange market.
Company Analysis ✓ Market Participants ✓ Key Strengths
Paid Sources
✓ ✓
Factiva Hoovers
13
Research Methodology Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of the global therapeutic plasma exchange market. The team has
analyzed the outlook of various segments of this market, while considering the major influencing factors such as rise in cases of chronic diseases. The study includes market forecasting, which would enable our clients to take better decisions while planning their strategy to achieve sustainability in the global therapeutic plasma exchange market.
Methodology Followed for Calculation of Market Size:
•
Market Size by Value: Market size, in terms of value, for the year 2019 was calculated based on information collected through exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as therapeutic plasma exchange companies, channel partners, market influencers & end users, industry experts, and other industry participants.
•
The team interviewed more than 15 – 20 therapeutic plasma exchange companies, 100 – 120 end users, and 15 – 20 industry experts and other value chain stakeholders in the global Therapeutic Plasma Exchange market to obtain the overall market size from 2015 to 2019, which was validated by the Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data during 2015-2019.
14
Research Methodology •
Respondents were asked about the current and future market growth rates, market shares by technique, by indication, by gender, by end use, by each region, and by company. Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various segments were further triangulated from other stakeholders.
Methodology Followed for Calculation of Market Shares: •
Market shares shares by technique, by indication, by gender, by end use, by each region, and by company were calculated based on the responses received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various segments of Therapeutic Plasma Exchange markets. The final shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers.
Methodology Followed for Forecasting: •
TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.
•
Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global Therapeutic Plasma Exchange market, TechSci Research used various forecast techniques such as: ✓
Moving Average
✓
Time Series Analysis
✓
Regression Analysis
✓
Econometric and Judgmental Analysis
15
Research Methodology TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market including market share data. The currency used in the report is the United States Dollar (USD), with the market size indicated in USD million. Partial List of Companies Interviewed
Key Secondary Sources
▪ Haemonetics Corporation
▪ World Bank
▪ Fresenius Medical Care
▪ TechSci Research Proprietary Database & Knowledge
▪ Terumo BCT, Inc.
Repository
▪ Baxter International Inc.
▪ Company Annual Reports
▪ Asahi Kasei Medical Co., Ltd.
▪ Industry Magazines
▪ Kawasumi Laboratories Inc.
▪ Industry Reports
▪ B. Braun Melsungen AG
▪ News Dailies
▪ HemaCare Corporation
▪ Credible Paid Databases
▪ Medica S.p.A. ▪ Cerus Corporation ▪ Nikkiso Co., Ltd. ▪ Miltenyi Biotec ▪ Therakos Incorporation ▪ Fenwal Incorporation ▪ Kaneka Corporation
16
Industry Brief According to TechSci Research report, “Global Therapeutic Plasma Exchange Market By Technique (Centrifugation v/s Membrane Separation), By Indication (Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders), By Gender (Male v/s Female), By End Use (Hospitals, Clinics, Others), By Region, Forecast & Opportunities, 2025”, the global market for therapeutic plasma exchange is expected to grow at a brisk CAGR during the next five years. The market growth is fueled by the utility of product in research organizations as it is being continuously tested for its efficacies under different conditions. Therapeutic plasma exchange is a process to separate blood from plasma by different procedures like membrane separation or centrifugation. This
is done to remove any particular disease that is present in plasma by replacing the blood with fresh frozen plasma (FFP) or albumin. The technique is called plasmapheresis which works by filtering harmful antibodies from the blood and is used in many chronic diseases, for instance, GBS (Guillain Barre Syndrome) is a type of disease where it is necessary to implement plasma exchange to save the life. However, process of plasmapheresis is quite costly which can hamper the growth of the market. Global therapeutic plasma exchange (TPE) market is segmented based on technique, indication, gender, end use and region. Indication segment is further divided into neurological disorders, renal disorders, hematology disorders and metabolic disorders. Out of these, neurological disorders are expected to hold the lion’s share as the TPE procedure has proved itself to be quite effective in the
treatment of various neurological disorders, like, Guillain Barre Syndrome (GBS). It is also used to treat severe and sudden attacks of sclerosis. American Society for Apheresis (ASFA) provides a set of regulated guidelines, which needs to be followed before using the procedure into any application. End use segment is divided into hospitals, clinics and others, out of which, hospitals held the largest share in 2019 and are expected to grow at the fastest rate during the forecast period. This growth can be attributed to the increase in the number of patients suffering from diseases that require plasmapheresis technique for their treatment. Based on regional analysis, the market has been segmented into Asia-Pacific, North America, Europe, South America and Middle East & Africa (MEA). North America held the dominant market
share in 2019 on account of presence of pharma & biotech companies. Moreover, the R&D sector in this region has been developing over years, which can be held responsible for the region’s market dominance. Some of the leading players in global therapeutic plasma exchange market include Haemonetics Corporation, Fresenius Medical Care, Terumo BCT, Inc., Baxter International Inc., Asahi Kasei Medical Co., Ltd., Kawasumi Laboratories Inc., B. Braun Melsungen AG, HemaCare Corporation, Medica S.p.A., Cerus Corporation, Nikkiso Co., Ltd., Miltenyi Biotec, Therakos Incorporation, Fenwal Incorporation, Kaneka Corporation, etc. “In terms of regional analysis, Asia-Pacific is expected to grow at the highest CAGR in during the forecast period which can be attributed to the rising healthcare facilities in developing countries like China, India, etc. Additionally, leading market players have commenced investing in the TPE procedures, which is also fueling the growth of the market. Moreover, in the region, China led the market in 2019 and India is anticipated to grow at the highest growth rate during the forecast period on account of increasing cases of autoimmune diseases and hematology disorders in the country.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
17
Sample Data - Snapshot Global Therapeutic Plasma Exchange Market Size, By Value (USD Million), 2015–2025F
5.00
2015
8.00
7.00
6.00
CAGR By Value
XX%
9.00
10.00
2019
2020E
11.00
14.00
13.00
12.00
CAGR By Value
2025F
YY%
By Value (USD Million)
15.00
North America Therapeutic Plasma Exchange Market Share, By Technique, By Value, 2015–2025F Centrifugation
Membrane Separation
50% 50% 50% 50% 50% 50% 50% 50% 50% 50% 50%
2025F 2024F 2023F 2022F 2021F 2020E 2019 2018 2017 2016 2015
50% 50% 50% 50% 50% 50% 50% 50% 50% 50% 50%
United States Therapeutic Plasma Exchange Market Share, By Indication, By Value, 2015–2025F Neurological Disorders 2025F 2024F 2023F 2022F 2021F 2020E 2019 2018 2017 2016 2015
25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%
Renal Disorders
25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%
Hematology Disorders
25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%
Metabolic Disorders
25% 25% 25% 25% 25% 25% 25% 25% 25% 25% 25%
18
Report Ordering
Report Name: GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET FORECAST & OPPORTUNITIES 2015 – 2025 License Type
Price
Single User License
$4450
Multi-User License
$5450
Custom Research License
$9450
To View Sample OR Purchase Report
19
About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas
to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.
Related Reports •
Global Medical Electronics Market By Product Type (Therapeutic and Diagnostics), By End-user (Hospital, Ambulatory Surgical Center, Clinic & Others), By Region (North America, Europe, Asia-Pacific & Others), Competition, Forecast & Opportunities, 2024
•
Global Medical Processing Seals Market By Type (O-Rings, Lip Seals, Gaskets & Others), By Material (Silicone, Metals, EPDM, PTFE, Nitrile Rubber & Others), By Application (Medical Devices & Medical Equipment), By Region, Competition, Forecast & Opportunities, 2024
TechSci Research – North America 708 Third Avenue, Manhattan, New York, United States Tel: +1- 646- 360- 1656 Email: sales@techsciresearch.com www.techsciresearch.com
TechSci Research – Europe
54, Old brook, Bretton, Peterborough, United Kingdom Email: sales@techsciresearch.com www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital Region, U.P. - India Tel: +91-120-4523900 Email: sales@techsciresearch.com www.techsciresearch.com
Disclaimer The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.